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A series of half-sandwich polypyridyl complexes was synthesized and compared focusing on structural, cytotoxic and 
aqueous solution behaviour. The formula of the synthesized complexes is [M(arene)(N,N)Cl]Cl, where M: Ru or Rh, arene: 
p-cymene, toluene or C5Me5
‒, (N,N): 2,2’-bipyridine (bpy), 4,4’-dimethyl-2,2’-bipyridine (dmb), 1,10-phenanthroline (phen) 
or 2,9-dimethyl-1,10-phenanthroline (neo). The structures of five half-sandwich complexes were determined by X-ray 
crystallography. It was found that introducing methyl groups next to the coordinating nitrogen atoms of the bidentate 
ligand causes steric congestion around the metal centre which changes the angle between ligand planes. The ligands and 
the Rh complexes showed significant cytotoxicity in A2780 and MES-SA cancer cell lines (IC50 = 0.1–56 μM) and in the 
cisplatin-resistant A2780cis cells. Paradoxically, phen and dmb as well as their half-sandwich Rh complexes showed 
increased toxicity against multidrug resistant MES-SA/Dx5 cells. In contrast, coordination to Ru caused loss of toxicity. 
Solution equilibrium constants showed that the studied metal complexes have high stability, and no dissociation was 
found for Ru and Rh complexes even at micromolar concentrations in a wide pH range. However, in case of Ru complexes 
a slow and irreversible decomposition, namely arene loss was also observed, which was more pronounced in light 
exposure in aqueous solution. In case of neo, the methyl groups next to the nitrogen atoms significantly decrease the 
stability of complexes. For Rh complexes, the order of the stability constants corrected with ligand basicity (log K*): 9.78 
(phen) > 9.01 (dmb) > 8.89 (bpy) > 3.93 (neo). The coordinated neo resulted in an enormous decrease in the chloride ion 
affinity of Ru compounds. Based on the results, a universal model was introduced for the prediction of chloride ion 
capability of half-sandwich Rh and Ru complexes. It combines the effects of the bidentate ligand and the M(arene) part 
using only two terms, performing multilinear regression procedure.  
Introduction 
Based on the success of cisplatin, complexes of other platinum 
group metal ions were developed and introduced into clinical trials. 
Ru(III) complexes, namely NAMI-A and BOLD-100 (formerly known 
as KP-1339)
1
 and the Ru(II) containing TLD1433 entered clinical 
trials.
1
 The proposed mechanism is that they are activated by 
reduction. Based on this idea several Ru(II) complexes have been 
synthesized, possessing an organometallic half-sandwich structure 
having a bidentate ligand and a monodentate leaving group. Early 
examples contained ethylenediamine and halide ion as ligands (the 
so-called RAED complexes),
1,2
 which were followed by the Os(II), 
Ir(III) and Rh(III) analogues and with different bidentate ligands. 
Some of these half-sandwich complexes showed remarkable 
cytotoxic activity and several structure-activity relationship analyses 
were conducted to identify the key chemical parameters.
1,3
 The 
mechanism of action of these compounds show a wide variety, as 
the RAED complexes are capable of DNA-binding,
4
 enzyme 
inhibition (cathepsin B, thioredoxin reductase),
5,6
 and the 





 show catalytic GSH oxidation.
7,8
 The latter is the 
primary mechanism of the ‘catalytic metallodrugs’.
9
 The group of 
Sadler proved the occurrence of intracellular catalysis by half-
sandwich complexes of (N,N) donor ligands, such as 
ethylenediamine, 2,2’-bipyridine (bpy) and 1,10-phenanthroline 
(phen).
10
 The reaction of these organometallic complexes with the 
NAD
+
/NADH pair was found in the presence of formate ions. 
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Polypyridines (phen and bpy) and their myriad derivatives are 
common ligands for half-sandwich complexes. Detailed solution 









. These ligands usually show similar or higher 
cytotoxic activity than their metal complexes.
12
 However, complex 
formation in general might have advantageous effects on the 
selective cytotoxicity on cancer cells, since it can change the overall 
charge, lipophilicity and size, which affect the pharmacokinetics and 
can also result in altered mechanism of action. Different biological 
effects were found for Ru/Rh polypyridyl complexes. DNA 
intercalation was reported in the coordinatively saturated and 
kinetically inert tris-polypyridyl Ru and Rh complexes, in which 
mostly phen and its derivatives are the ligands.
18,19
 On the other 
hand, taking into consideration the viscosity measurements, 
cytotoxicity data and ultrafiltration measurements, DNA-
intercalation is not likely to occur and DNA is not believed to be the 





 There are also examples for 
topoisomerase I and II inhibitors,
23




In the field of cancer treatment, one of the major impediments is 
the appearance of resistance to chemotherapeutic agents. Cellular 
mechanisms promoting multidrug resistance (MDR) often rely on 
the elevated expression of ATP-binding cassette proteins, which 
pump a wide variety of drug molecules from the cell.
25-27
 Drug 
resistant cells resort to further mechanisms in the case of 
compounds that are not recognized as transported substrates. In 
the case of cisplatin, cells become resistant as a result of elevated 
glutathione concentrations and increased DNA-repair.
26
 
Interestingly, the majority of RAED compounds seemed to 
overcome cisplatin resistance in the A2780cis cell lines model.
3
 
Similarly, a Ru cyclopentadienyl complex containing 4,4’-dimethyl-
2,2’-bipyridine (dmb) showed comparable activity in parental and in 
cisplatin-resistant cancer cells.
28
 In our former studies, we reported 
half-sandwich complexes with high stability, in which the ligands 
were 8-hydroxyquinoline derivatives.
29,30
 The ligands substituted at 
the 7
th
 position showed preferential toxicity in otherwise multidrug 
resistant MES-SA/Dx5 and Colo320 cell lines, and this characteristic 












 resulted in a decrease in 
cytotoxicity and the loss of preferential toxicity.
29,30
  
In this study, we selected four polypyridines and their half-sandwich 









Scheme 1 Synthesis procedure of the complexes. 
structure, aqueous solution behaviour and anticancer activity 
against parental and drug resistant cancer cell lines. We synthesized 
novel Ru(
6
-toluene) to investigate the effects of the exchanges of 
p-cymene to toluene, and 2,9-dimethyl-1,10-phenanthroline 
(neocuproine, neo) complexes were also prepared to reveal the 
effect of methylation close to the coordinating nitrogens. 
 
Results and discussions 
Synthesis and characterization of complexes 
As illustrated in Scheme 1, synthesis of complexes with the general 
formula [M(arene)(N,N)Cl]Cl, where M: Ru or Rh, arene: p-cymene 
(p-cym), toluene (tol), C5Me5
‒
, (N,N): bpy, dmb, phen and neo, was 
performed according to previously described methods.
11,31-33
 
Among the listed complexes, Ru(
6
-tol) complexes and neo 
complexes are new compounds. In this work, all the 
[M(arene)(N,N)Cl]Cl complexes were obtained as orange solids with 
moderate-to-excellent yields (45-95%) using methanol (MeOH) as 
solvent. Notably, the neo complexes were isolated in the lowest 
yields, which could be improved by using an excess of the ligand. 
[Ru(
6
-p-cym/tol)(ethylenediamine)Cl]Cl complexes are well-known 
compounds,
2
 they were also synthesized with the same method for 




C NMR spectra recorded in CD3OD confirmed complex 
formation, as shown in Figures S1-S14. Deuteration of the C5Me5 





NMR spectra, as three peaks are shown in Figure S7 with the same 
intensity next to the peak of the methyl groups. ESI-MS spectra 
were recorded only for the novel complexes, and the results 
confirmed the stoichiometry of each complex (Figures S15-S21). 
Stability and photosensitivity of the complexes were investigated in 
water (at pH 7.4). Notably, the Rh complexes were stable in water 
for at least 7 days, as the yellow colour and the 
1
H NMR spectra 
remained unchanged (see Figure S22 as an example). In order to 














 were prepared and followed in time by UV-
visible (UV-Vis) spectrophotometry. One of the parallel samples was 
protected from light, while the other was exposed to diffuse solar 
irradiation. The starting solutions had yellow colour, which is typical 
for half-sandwich complexes. Spectra of the complexes (shown in 





, which showed signs of decomposition after 
18 h (Figure S23.a). Namely, the sample turned blue-green, and a 
new band developed in the UV-visible (UV-Vis) spectra, first after 
18 h with max = 588 nm, and after 6 days another band appeared 
with max = 644 nm. When exposed to light for a longer period of 
time, all samples showed signs of this process, which is most 
probably linked to the irreversible decomposition of the half-





 is slower than that of the toluene 
analogue, which appears only after more than 1 day. The product 
has the same max at 588 nm (Figure S23.b), which is indicative of 




 has a 
max = 658 nm, where a tiny amount (Amax~0.03) appears only in 
light after 4 days (Figure S23.c). These experiments suggest that the 
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metal−carbon bond in the organometallic moiety can break and 
both the type of the metal ion and the arene have important roles 
in the stabilization: the bond between Ru(II) and p-cymene is more 
stable than between Ru(II) and toluene, while the bond between 
Rh(III) and C5Me5
-
 is the strongest in this set of complexes. In case 
of Ru complexes formed with other (N,N) bidentate ligands, the loss 
of the arene ligand was reported earlier.
34
 In our previous studies, 
arene loss induced by ligand excess or by another coordinating 
bidentate ligand was observed.
29,30
 Stability studies of the bpy 
complexes was followed in the cell culture medium Roswell Park 
Memorial Institute Medium 1640 (RPMI 1640) completed with fetal 
bovine serum (FBS) in dark. Under these conditions no arene ligand 
dissociation was detected (Figure S24). 
Reactions of the complexes in the cell culture medium Dulbecco’s 
Modified Eagle Medium (DMEM) was also followed for a week by 
1
H NMR spectroscopy. This medium provides physiological pH and 
contains inorganic salts, amino acids, sugar and vitamins, which 
may interact with these complexes. Figure S25 shows the important 
ranges of the recorded spectra, focused on the interactions with 









 complexes after 5 h new peaks 
appeared showing the formation of mixed ligand complexes. After 
this period, no big changes in the spectra could be observed after 
one week, except in the case of neo complexes, which showed a 





 partially dissociated even in the phosphate 
buffer, indicating its lower stability at pH = 7.40. The measurements 
were repeated in RPMI 1640 medium completed with FBS (Figure 





 complex compared to the spectra measured 
in DMEM. 





-C5Me5) organometallic cations are 
well-known and several examples show the complexes in 
chlorinated
3,12,13,20
 or in aqua form
35,36
 in the solid structures. The 
different arene ligands did not change the piano-stool shaped 
structure. However, Ru−N and Ru−ring centroid distances can vary 
in these complexes. Generally, the structures represent mono 
complexes, in which the ligands are bound to the metal centre 
through two nitrogen atoms.  
After counter ion exchange (Cl
-
 to CF3SO3), single crystals for 
complexes [Rh(
5
-C5Me5)(dmb)Cl](CF3SO3) (crystal I), [Ru(
6
-
tol)(dmb)Cl](CF3SO3) (crystal II) and [Ru(dmb)3](CF3SO3)2×2 H2O 
(crystal III) were obtained, which were subjected to X-ray 
crystallographic structure determination. Crystal data and structure 
refinement parameters are collected in Table S1. The results proved 





















 However, a dark red crystal was also isolated that 
showed evidence of arene loss and the formation of 
[Ru(dmb)3](CF3SO3)2×2 H2O with octahedral structure. This 
irreversible reaction occurred in organic solvents and in water as 
well (vide supra), as the colour of solutions turned to green-blue 
over time. The [Rh(
5

















Fig. 1 Molecular structures of a) [Rh(5-C5Me5)(dmb)Cl](CF3SO3) (I), b) 
[Ru(6-tol)(dmb)Cl](CF3SO3) (II) c) [Ru(dmb)3].2(CF3SO3)×2 H2O (III), d) 
[Ru(6-tol)(neo)Cl]Cl×2 MeOH (IV), e) [Ru(6-p-cym)(neo)Cl](CF3SO3) (V) and 
f) [Rh(5-C5Me5)(neo)Cl](CF3SO3) (VI). Hydrogen atoms, solvent molecules 
and counter ions are omitted for clarity. Displacement ellipsoids are drawn 
at 50% probability level. 
 
in the orthorhombic and both Ru complexes in the monoclinic 
crystal systems in Pbcn, P21/n and P21/c space groups, respectively, 
with the inclusion of a CF3SO3
-
 counter ion (and two water 
molecules in the latter) per asymmetric unit. The ORTEP 
representation of the compounds is depicted in Figure 1.a,b,c. 
Crystal structures of [Ru(
6
-tol)(neo)Cl]Cl×2 MeOH (crystal IV), 
[Ru(
6
-p-cym)(neo)Cl](CF3SO3) (crystal V) and [Rh(
5
-
C5Me5)(neo)Cl](CF3SO3) (crystal VI) could be also obtained 
(Figure 1.d,e,f). Crystal data and structure refinement parameters 
for neo complexes are collected in Table S2. Crystal IV and V 
crystallized in the monoclinic and crystal VI in the triclinic crystal 
systems in P21/c (IV, V) and P-1 (VI) space groups. The asymmetric 
unit contains one complex and one counter ion in crystal V, two 
extra MeOH molecules in crystal IV and two complexes with two 
counter ions in crystal VI. Selected bond lengths and angles are 
collected in Tables S3-S4. In the the neo complexes, the neo ligand 
is not fully planar. The angle enclosed by the planes of the outer 
ring is bended for IV and V (12.7° and 9.8°, respectively) and the 
most bent ring was found in crystal VI where this angle is 17.2° and 
17.7° for molecules 1 and 2. The bar chart in Figure S27 shows the 
metal ion−N atom distances, which are longer for neo complexes 
and are the shortest in the tris-dmb complex. 







 are practically identical as the average Ru−N 
bond lengths are 2.088 Å vs. 2.085 Å, the Ru−ring centroid distances 
are 1.686 Å vs. 1.685 Å. The two Ru complexes of neo also show a 
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geometrical parameters (Figure S28.a). The geometrical changes are 
negligible when p-cymene is substituted to toluene ligand.  
All neocuproine containing structures differ from the analogous 
phen complexes,
13,20
 as the steric congestion around the metal ion 




 positions. For 
instance the Rh−N bond length changed from 2.11 Å to 2.13 Å, in 
case of exchanges of phen to neo change. A spectacular proof of the 
steric hindrance is the finding that the planes of the arene ligand 










complexes is shown in Figure S28.b.
13
 In this example there is a 19° 
alteration between the plane of phen and neo. The best 
visualization for this steric congestion is provided by the ligand solid 
angles calculated by the Olex2 software.
38,39
 Figure S29 shows the 





two different views. Less overlap is present between the ligands 
around Rh(III) than in the two Ru(II) complexes (see more details in 
the legend of Figure S29). For crystallization of all neocuproine 
complexes we also tried to perform anion exchange using 
Ag(CF3SO3) salt. However, during the crystallization procedure, red 
crystals of the precursor [M(arene)Cl2]2 dimer and colourless 
crystals of [Ag(neo)2](CF3SO3) appeared in these samples, most 
probably as a consequence of the low stability of the neocuproine 
complexes (notably they were also characterized by the lowest 
yields in synthesis). Scheme S1 shows side reactions of neocuproine 
complexes.  
 
In vitro anticancer activity 
The anticancer activity of four related polypyridyl ligands (phen, 







-C5Me5) complexes was investigated against the uterine 
sarcoma cell line MES-SA and its doxorubicin resistant counterpart 
MES-SA/Dx5, as well as against the ovarian cancer cell line A2780 
and its cisplatin resistant counterpart A2780cis. A2780cis cells show 
an increased ability to repair DNA and have higher intracellular 
concentrations of glutathione,
26
 while MES-SA/Dx5 cells 
overexpress P-gp,
26,40
 which results in multidrug resistance.  
The paradoxical toxicity of phen against P-glycoprotein (P-gp)-
expressing MDR cells (MDR-selective toxicity) was reported 
earlier.
41
 A summary of the literature data on the in vitro toxicity of 
the half-sandwich complexes of the selected ligands on other 




The obtained IC50 values are shown in Tables 1-2 and in Figure S30. 
The relative toxicity of the complexes against parental and drug 
resistant cancer cell lines was compared, and the selective toxicity 
was expressed as resistance ratio (RR = IC50 (resistant cell) / IC50 
(sensitive cell)). Based on the determined IC50 values (Tables 1-2), 
the ligands phen, neo and dmb displayed significant toxicity, 
reaching submicromolar IC50 values in some cases. Neocuproine has 
a superior cytotoxic effect, it is comparable with doxorubicin (and 
10 times higher than phen) in MES-SA cells, while 20 times more 





 complexes were similar or slightly lower compared 
to that of their corresponding ligands. Surprisingly, the Ru 
complexes exhibited in all cases weaker cytotoxicity than the Rh 
congeners. 
Table 1 In vitro cytotoxic effects (72 h) (IC50 values in M) in parental (MES-
SA) and multidrug resistant (MES-SA/Dx5) cell lines treated with 
polypyridine ligands and their half-sandwich complexes in addition to the 
corresponding organometallic precursors. Resistance ratio (RR = IC50(MES-
SA/Dx5)/IC50(MES-SA)) values are also represented. N. d. = not determined 





phen 4 ± 1 1.30 ± 0.01 0.33 
[Rh(5-C5Me5)(phen)Cl]Cl 8 ± 2 2.0 ± 0.9 0.25 
[Ru(6-tol)(phen)Cl]Cl > 100 > 100 n. d. 
[Ru(6-p-cym)(phen)Cl]Cl 24 ± 12 > 100 >4.2 
neo 0.37 ± 0.08 0.30 ± 0.04 0.81 
[Rh(5-C5Me5)(neo)Cl]Cl 1.4 ± 0.1 2.66 ± 0.09 1.90 
[Ru(6-tol)(neo)Cl]Cl 2.1 ± 0.2 4.2 ± 0.7 2.00 
[Ru(6-p-cym)(neo)Cl]Cl 4 ± 1 7 ± 1 1.75 
bpy 66 ± 19 50 ± 15 0.75 
[Rh(5-C5Me5)(bpy)Cl]Cl > 100 69 ± 25 <0.7 
[Ru(6-tol)(bpy)Cl]Cl > 100 > 100 n. d. 
[Ru(6-p-cym)(bpy)Cl]Cl > 100 > 100 n. d. 
dmb 46 ± 7 15 ± 2 0.33 
[Rh(5-C5Me5)(dmb)Cl]+ 41 ± 6 16 ± 6 0.39 
[Ru(6-tol)(dmb)Cl]+ > 100 > 100 n. d. 
[Ru(6-p-cym)(dmb)Cl]+ 63 ± 11 > 100 >1.59 
[Rh(5-C5Me5)Cl2]2 > 100 > 100 n. d. 
[Ru(6-tol)Cl2]2 > 100 > 100 n. d. 
[Ru(6-p-cym)Cl2]2 > 100 > 100 n. d. 
doxorubicin 0.35 ± 0.06 3 ± 0.9 8.57 
 
Table 2 In vitro cytotoxic effect (72 h) (IC50 values in M) of polypyridine 
ligands and their half-sandwich complexes in addition to the organometallic 
precursors in sensitive (A2780) and cisplatin resistant (A2780cis) human 
ovarian cancer cell lines. Resistance ratio (RR = IC50(A2780cis)/IC50(A2780)) 
values are also represented. N. d. = not determined (in cases where both 
IC50 > 100 M). 
 A2780 A2780cis RR 
phen 0.14 ± 0.03 2.5 ± 0.2 17.9 
[Rh(5-C5Me5)(phen)Cl]Cl 0.28 ± 0.09 10 ± 3 35.7 
[Ru(6-tol)(phen)Cl]Cl 38 ± 12 > 100 >2.6 
[Ru(6-p-cym)(phen)Cl]Cl 11 ± 2 > 100 >9.1 
neo 0.13 ± 0.03 9 ± 2 69.2 
[Rh(5-C5Me5)(neo)Cl]Cl 0.4 ± 0.2 1.2 ± 0.3 3.0 
[Ru(6-tol)(neo)Cl]Cl 0.6 ± 0.1 1.5 ± 0.3 2.5 
[Ru(6-p-cym)(neo)Cl]Cl 2 ± 1 6 ± 4 3.0 
bpy 2.4 ± 0.8 39 ± 20 16.3 
[Rh(5-C5Me5)(bpy)Cl]Cl 7 ± 3 > 100 >14.3 
[Ru(6-tol)(bpy)Cl]Cl 11.2 ± 0.9 > 100 >8.9 
[Ru(6-p-cym)(bpy)Cl]Cl 19 ± 5 > 100 >5.3 
dmb 0.13 ± 0.07 35 ± 6 269 
[Rh(5-C5Me5)(dmb)Cl]+ 0.4 ± 0.2 57 ± 10 143 
[Ru(6-tol)(dmb)Cl]+ ~100 > 100 >1.0 
[Ru(6-p-cym)(dmb)Cl]+ 13 ± 3 57 ± 9 4.4 
[Rh(5-C5Me5)Cl2]2 45 ± 6 > 100 >2.2 
[Ru(6-tol)Cl2]2 > 100 > 100 n. d. 
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[Ru(6-p-cym)Cl2]2 > 100 > 100 n. d. 












Fig. 2 Effect of the P-gp inhibitor TQ on pIC50 values in MES-SA and MES-
SA/Dx5 cells. Doxorubicin and compounds with paradoxical cytotoxicity are 
shown. ‘Rh-dmb’ and ‘Rh-phen’ represent the corresponding [Rh(5-
C5Me5)(N,N)(H2O)]
2+ complexes. Points above the diagonal represent 
paradoxical behaviour; points on the diagonal show compounds, whose 
cytotoxic effect is the same on both cell lines; points under the diagonal 
display lower toxicity in MES-SA/Dx5 than in MES-SA. △: without TQ; ●: co-
incubated with TQ. Arrows show the effect of TQ on the activity, which is 
decreased in the case of compounds with paradoxical toxicity (red) 
potentiated by P-gp, while increased for non-selective compounds (green). 
 
As compared to A2780 parental cells, the cisplatin-resistant 
A2780cis cells were found to be cross-resistant to all investigated 
compounds (c.f. IC50 values in Table 2). However, the RR values are 
smaller for the neocuproine complexes unlike the ligand or the 
cisplatin itself. Interestingly, ligands phen, dmb and their Rh 
complexes showed higher cytotoxicity in MES-SA/Dx5 cell lines than 
in the MES-SA cells (RR < 0.5 in Table 1), suggesting that these 
compounds may show MDR-selective activity.
25
 However, despite 
the similar structures of neo and phen or bpy and dmb, neo and bpy 
showed no preferential toxicity against MES-SA/Dx5 cells. The 




To test the relevance of P-gp function in the selective toxicity of 
phen, dmb and their Rh complexes, the in vitro toxicity assays were 
repeated in the presence of the P-gp inhibitor tariquidar (TQ) in 
MES-SA and MES-SA/Dx5 cell lines (Figure 2, Table S5). As expected, 
the IC50 of doxorubicin significantly decreased (pIC50 increased), in 
line with the inhibition of drug efflux. In contrast, phen, dmb and 
their Rh complexes show decreased toxicity in the presence of TQ, 
proving that their activity is potentiated by P-gp. The most 
prominent example is dmb, where the IC50 in MES-SA/Dx5 cells 
changes from 15 M to 72 M upon addition of TQ, respectively. 
As a conclusion, phen, dmb and their Rh complexes were found to 
be cytotoxic, and showed preferential cytotoxicity in the MES-
SA/Dx5 cell-line. Exchange of Rh to Ru results in the loss of activity 
and selectivity, as it was found in our previous publications for 
ligands with (N,O) donor set.
29,30
 In line with the results reported for 
these 8-hydroxyquinoline complexes
14,15
 irreversible arene loss was 
found for Ru complexes, and a somewhat higher cell accumulation 
was detected in the case of Rh. These findings might contribute to 
the different anticancer properties of the Ru and Rh polipyridyl 
complexes as well. In case of the Ru complexes, which were 
characterized in this work, arene loss was demonstrated even 
without an extra ligand (vide supra), which might be responsible for 
the observed loss of cytotoxicity in parental and/or resistant cell 
lines. Since the methylation of ligands (phen and bpy to neo and 
dmb), and the type of the metal centre (Ru or Rh) strongly affect 
the toxicity in the MES-SA and the MDR counterpart MES-SA/Dx5 
cell lines, further studies were performed in order to better 
understand the differences in the solution behaviour of these 
complexes. The A2780cis cells showed cross-resistance for these 
compounds, however, cells were less cross-resistant for the 
complexes of neocuproine, as the RR values indicate.  
 
Deprotonation of ligands and hydrolysis of half-sandwich cations 
Hydrolysis of the organometallic cations and the protonation 
constants of the ligands influence the solution speciation of metal 














) were already investigated in detail earlier.
45,46
 Proton 
dissociation constants of bpy, phen and ethylenediamine (Table 3) 
are also known under various conditions,
47,48
 and were re-
determined herein by pH-potentiometry (see detailed description 
of this method in ESI). Due to the limited water solubility of dmb 
and neo, only spectrophotometric titrations were feasible for these 
ligands in chloride-free medium (I = 0.20 M KNO3) using lower 
concentrations.  
Table 3 Proton dissociation constants (Ka (H2L) and Ka (HL)) for (N,N) ligands, stability (K [M(arene)(L)]), proton dissociation (Ka [M(arene)(L)]) and water-
chloride exchange (K’ (H2O/Cl
-)) constants of complexes of phen, neo, bpy, dmb and en. {T = 25.0 °C; I = 0.20 M (KNO3)}
 
M(arene) Constant phen neo bpy dmb en 
 pKa(HL) 4.92




log K [M(arene)(L)] 14.70(3)c 9.70(3)d 13.30(2)c 14.32(2)c 15.04b 
pKa [M(arene)(L)] 8.58
a 8.88(1)e 8.61b 8.40(1)f 9.58b 
log K’ (H2O/Cl
-) 2.92a 2.76(1)g 2.58b 2.36(1)g 2.14b 
Ru(6-p-cym) 
log K [M(arene)(L)] >12.8 8.21(4)e >12.5 >12.8 14.85(5)h 
pKa [M(arene)(L)] 7.59(1)
f 7.62(1)e 7.48(1)f 7.55(1)f 8.14(2)e 
log K’ (H2O/Cl
-) 1.79(1)g 0.93(1)g 1.83(1)g 2.02(1)g 1.51(5)g 
Ru(6-tol) 
log K [M(arene)(L)] >13.0 8.19(8)e >13.0 >13.2 14.90(6)h 
pKa [M(arene)(L)] 7.39(1)
f 7.55(1)e 7.39(1)f 7.47(1)f 8.04(2)e 
log K’ (H2O/Cl
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a See Ref. 22. b See Ref. 49. c 1H NMR, displacement measurements. d 1H NMR, pH = 0.7-2.1. e 1H NMR titrations, pH = 2.0-11.5. f UV-Vis titration, pH = 2-
11.5. g UV-Vis, c(Cl-)=0.0-0.2 M. h 1H NMR, c(M(arene)) = 100 M, c(ethylenediamine) = 0-7.3 mM. 
Considering the different ionic strengths, values are in good 
agreement with literature data.
47,48
 We find that methylation in 
ortho and in para positions increases the pKa. Based on the pKa 
values it can be concluded that the polypyridyl ligands are mainly in 
their neutral form at physiological pH. 
 




Based on the single-crystal X-ray structures and previous solution 
equilibrium studies on similar complexes,
3,13,22,49
 these bidentate 
(N,N) donor ligands form mono complexes with half-sandwich 
organometallic triaqua cations. Scheme S2 shows the occurring 
equilibrium processes in aqueous solutions for these complexes. 
Although the complex formation equilibrium is reached with (O,O) 
donors within minutes, hours or days are needed in case of the 
(N,N) donors.
22
 Complex formation rates at pH = 0.7 and 2.1 are 










 with the same ligand (h versus min). Generally, it 
can be concluded that the reaction rate is lower at more acidic pH. 
However, the pH cannot be increased beyond a certain limit to 
accelerate the reaction, since the hydrolysis of the organometallic 
cations produces inert hydroxido complexes. 
Complexes of bpy, dmb and phen are present in aqueous solutions 
at pH = 2 and 0.7 exclusively, there is no sign of unbound 
organometallic cation or ligand under the given conditions (I = 
0.20 M KNO3, aqueous solution) based on the 
1
H NMR spectroscopic 
measurements. (Notably, pH 0.7 is the lowest pH where the ionic 
strength can be kept constant.) With decreasing concentrations 









, the molar UV-Vis spectra remain unchanged 
(Figure S34), which also confirmed the high stability of the 
complexes. Since measurements with decreasing pH (down to 0.7) 
or concentration (down to 20 M) do not give any information 
about the stability constants owing to the lack of complex 
dissociation, displacement studies were performed with 










 was reported earlier).
49
 
Samples were prepared at pH = 3.0 using different 
ethylenediamine-to-Ru ratios (up to 14-fold ligand excess) and 
measured by 
1
H NMR spectroscopy. Figure S35 shows extremely 
slow complex formation under the conditions used. 
When ~80-fold excess of ethylenediamine was used, signals of 
mixed ligand complexes appeared in the 
1
H NMR spectra instead of 










systems, in which two peaks indicated the monodentate 
coordination of ethylenediamine. This ternary complex formation 



















Fig. 3 a) Selected 1H NMR spectra of the [Rh(5-C5Me5)(bpy)(H2O)]
2+-HQCl-
Pro (1:x) system at different HQCl-Pro concentrations (x = 0-22.5). Intensity 
is decreased in  < 2.0 ppm region for the sake of clarity. I.: spectrum of 
[Rh(5-C5Me5)(bpy)(H2O)]
2+; II.: spectrum of unbound bpy at pH 6.19; III.: 
spectrum of [Rh(5-C5Me5)(L)(H2O)]
+, where L is the deprotonated 
(coordinated) form of HQCl-Pro. Peaks signed with * belong to the unbound 
HQCl-Pro; ■ shows the peak of bpy used for calculations; dashed rectangle 
shows [Rh(5-C5Me5)(L)(H2O)]
+; solid rectangle shows [Rh(5-
C5Me5)(bpy)(H2O)]
2+. b) Measured and fitted (dashed line) percentages of 
[Rh(5-C5Me5)(L)(H2O)]
+; ■ is calculated from integrals of unbound-bound 
bpy peaks, ◊ is calculated from C5Me5 peaks. {c([Rh(
5-C5Me5)(H2O)3]
2+) = 
c(bpy) = 200 M; c(HQCl-Pro) = 0-4.53 mM; pH = 6.51; solvent: 90% H2O / 
10% D2O; T = 25.0 °C; I = 0.20 M (KNO3)} 
 
An 8-hydroxyquinoline derivate ((S)-5-chloro-7-((proline-1-
yl)methyl)8-hydroxyquinoline (HQCl-Pro))
30
 was used for the 
competition experiments, however, its use was limited only to the 
Rh-containing compounds, as the Ru complexes seem to lose the 
arene ligands when a competitor ligand is added. A successful 
displacement of bpy from its Rh complex is shown in Figure 3, at 
22.5-fold excess of HQCl-Pro ~70% of the liberated bpy. From this 
data a log K = 13.30(2) was calculated (Table 3). Bpy was employed 
for the displacement of dmb and phen ligands. In these 
measurements 
1
H NMR spectroscopy was used, since the peak 
separation of these similar compounds is satisfactory on NMR 
spectra (Figures S37 and S38). To determine the stability constants 
of the Ru complexes, we attempted to study a potential 
displacement between the organometallic cations. Unfortunately, 









, even at 10-fold excess of the latter. In 
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The behaviour of neocuproine complexes is different due to the 
steric effect of the methyl groups next to the donor atoms, namely 
the complex formation reaction is much slower as compared with 




 and neocuproine 
in 1:1.2 ratio were followed by 
1
H NMR spectroscopy for 15 days 
(Figure 4.a). An extra set of peaks belongs to an intermediate 
complex which is most probably a sandwich-type complex is 
(Figure 4.b,c). The solution stability of metal complexes also 
changed compared to phen. Free neocuproine occurs next to its Rh 
complex (pH = 0.7, ~50%, Figure S39.a) in the equilibrium, as well as 
next to the Ru complexes (pH = 2.5, ~15%, Figures 5.a and S40.a). 
Based on the samples measured for samples with acidic pH, molar 
fractions for bound and unbound neocuproine can be calculated 
and used for the determination of stability constants (Figure S39 
shows this in case of Rh). The Ru-containing complexes have smaller 
stability constants (Table 3). The lower complex stability constants 
and the stronger bias of [Ru(arene)(H2O)3]
2+
 towards hydrolysis 
ensure the lower aqueous stability of [Ru(arene)(neo)(H2O)]
2+
 




. The lower stability 
may originate from the shorter distance between the Ru metal ion 
and arene ligand compared with the Rh‒C5Me5 distance (1.697 Å vs. 
1.780 Å), which may cause greater steric repulsion around the Ru 
centre. To quantify this steric repulsion, the overlaps between 
ligand solid angles (calculated by Olex2
38
) were listed in the legend 



















Fig. 4 a) Time-dependence of complex formation of [Ru(6-tol)(H2O)3]
2+ with 
neo at pH = 6.0 followed by 1H NMR spectroscopy (only region of ligand is 
shown). Time of reaction is shown on the left. Assignment: bidentate metal 
complex: ■, free neo: ♠, ‘sandwich intermediate’: ♥. Arrows show the 
unusually big shifts of ‘sandwich intermediate’ from free ligand, which 
differences are shown in b) (in ppm). c) Proposed structure of the ‘sandwich 
intermediate’. {c([Ru(6-tol)(H2O)3]
2+) = 200 M; c(neo) = 245 M; pH= 6.0 
(20 mM phosphate); I = 0.20 M (KNO3); T = 25.0°C} 
Comparison of the stability constants of Rh complexes is not 
feasible due to the different basicity of the ligands. The derived 
stability constants are calculated as the equation shows below: 
log K* = log K [M(arene)(L)(H2O)]
2+
 ‒ pKa(HL) 





values show the following trend: 9.78 (phen) > 9.01 (dmb) > 8.89 
(bpy) > 3.93 (neo). While methylation far from the coordinating 
nitrogen atoms (bpy vs. dmb) causes slight difference, the 
methylation next to the coordinating nitrogen atoms results in a 
huge difference. However, except neocuproine, there are no 
significant differences in the stability of these Rh complexes. The 





 can be partly explained by the probable 
dissociation of neo-complex in the cell. However, the small stability 
difference between bpy and dmb cannot be the reason of the 
different behaviour against MDR cell lines. Moreover, the question 
arises whether the reactivity of the coordinated water molecule can 
be tuned using steric control of a bulky bidentate ligand. 
 
Reactions of the coordinated water molecule: deprotonation and 
substitution to chloride ion 
In half-sandwich complexes, next to the arene hapto ligand and a 
bidentate (N,N) donor ligand, the coordination sphere is completed 
by a water molecule, which can either lose a proton or can be 
substituted by another ligand (for example Cl
-
 in Scheme S2). Chen 
and co-workers found that the reaction of RAED complexes with 
nucleobases is slower at higher pH or in the presence of chloride or 
phosphate anions.
50
 At higher pH, deprotonation occurs, which is 
characterized by the pKa[M(arene)(L)] constant. With the 
knowledge of pKa values one can calculate not only the actual 
average charge (between +2 and +1) of the compound at a given 
pH, which has an effect also on lipophilicity, but also the molar 




Increasing the pH, the effect of the deprotonation process on the 
UV-Vis spectra is unambiguous, as the pH-dependent spectra 




) shows. From 
the absorbance change pKa values can be computed. Determination 
of this constant is also feasible by performing 
1
H NMR titrations, 
where the changes of the chemical shifts are used for calculations. 





 was determined as 7.32 in pure D2O,
42
 which is 
in good agreement with the constant reported here. This type of 





and interestingly, in the region of aromatic p-cymene protons a 
singlet appears, which belongs to the arene in the complex 
(Figure 6). This peak belongs to protons, which are generally not 
magnetically equivalent in other complexes. As the pH increases, 
this singlet splits into two doublets.  
 
     
 (ppm)
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Fig. 5 a) UV-Vis spectra of the [Ru(6-tol)(dmb)(H2O)]
2+ recorded at pH = 5.1-
9.9. b) Absorbance change at 364 nm in dependence of the pH. {c([Ru(6-
tol)(dmb)(H2O)]
2+) = c(dmb) = 200 M; I = 0.20 M (KNO3); ℓ = 1 cm; T=25.0°C} 
 
As shown in Table 3, methylation of the polypyridine ligands has an 
influence on the deprotonation of the coordinated water molecule. 
Namely, the methyl groups increase the pKa values of the 
complexes in all cases. Ru complexes have stronger OH
-
 affinity than 
the Rh analogues, as the lower pKa values indicate it. Due to the 
lower complex stability, at physiological pH [(Ru(arene))2(OH)3]
+
 
also appears in the case of [Ru(arene)(neo)(H2O)]
2+
 complexes.  
Chloride ions can potentially replace the coordinating water 
molecule, as shown in the single-crystal XRD structures (Figure 1), 





 is present in aqueous solutions, e.g. in 
biofluids, where the concentration drops from 103 mM to 24 mM 
and 4 mM, entering from the blood serum to cytoplasm and 
nucleus.
51
 The coordination of Cl
-
 affects the actual charge and the 
presence of chloride ion in medium can suppress the deprotonation 














 was already reported by our group.
22,49
 Upon 
addition of chloride ions, changes similar to deprotonation can be 





 in Figure 7.a). From the spectral changes the 
water-chloride exchange constants were calculated (Table 3). 
Methylation of the ligands has an effect on the water-chloride 
exchange constant as well. While for Rh complexes only a slight 
decrease can be seen, the effect for Ru complexes is remarkable. 
The Cl
-
 affinity of dmb complexes is higher than that of the bpy 
complexes. The Ru(II)-arene complexes of neocuproine have 
significantly low constants: log K’(H2O/Cl
-
) = 1.79→0.93 and 
1.68→0.87 (Table 3). The Cl
-
































Fig. 6 a) Aromatic region of selected 1H NMR spectra of the [Ru(6-p-
cym)(neo)(H2O)]
2+ system recorded at pH = 2.0-11.4 after 34 days. Peaks of 
complex I are signed with *. Appearance of ‘sandwich intermediate’ is 
shown in the inset. b) Measured (neo H at position 5 and 6: □; all protons of 
ligand: ×) and fitted (dashed line) ratio of formed complex. c) Measured (○) 
and fitted (dashed line) chemical shift values of aromatic p-cymene protons 
at different pH-values. {c([Ru(6-p-cym)(H2O)3]
2+) = c(neo) = 500 M; solvent: 
90% H2O / 10% D2O; T = 25.0°C; I = 0.20 M (KNO3); c(phosphate) = 20 mM} 
 
Figure S40.b. Most probably a steric repulsion is the reason. The 
methyl groups of neo hinder the strong interaction between the 
chloride ion and Ru. 
For [Ru(arene)(ethylenediamine)(H2O)]
2+
 complexes, a larger 
uncertainty can be seen in the constants. This is in connection with 
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abovementioned work of Chen et al.,
50
 and on our measurements 
showed in details in Figures S41-S42. 
Figure 7.c shows the ratio of chlorinated and aqua forms of 




















Fig. 7 a) UV-Vis spectra of [Ru(6-tol)(phen)(H2O)]
2+ recorded at various 
chloride ion concentrations. b) Absorbance change at 346 nm plotted 
against the concentration of the chloride ion. c) Ratio of the aqua and 
chlorinated forms of complexes (c = 200 M) with the highest and lowest 
chloride affinity measured in the studied group of compounds. Chloride 
concentrations are representing the different biofluids. Constants from 
Table 3 were used for calculation. {c([Ru(6-tol)(H2O)3]
2+) = c(phen) 
=  182 M; pH = 6.0; ℓ = 1 cm; T = 25.0°C} 
 
Our calculations show the contrasting behaviour of two complexes, 










respectively). As seen in Figure 7.c, the fraction of the chlorinated 
form of the neo complex is minimal at c(Cl
-
) = 4 mM, and it 
increases to 43% at c(Cl
-





 complex shows an opposite behaviour, as the 
chlorinated form predominates under all considered chloride ion 
concentrations.  
The importance of the knowledge of chloride ion affinity was 
already mentioned above and in previous reviews.
51
 In our earlier 
work, a linear relationship between the pKa[M(arene)(L)] and the 
log K’(H2O/Cl
-
) constants was found for Rh(
5
-C5Me5) complexes 
with (O,O), (O,N), (N,N) and (O,S) donor bidentate ligands. To 
complete this model, already published and the newly determined 
constants even for Ru(arene) complexes were integrated (except 























Fig. 8 a) The measured log K’(H2O/Cl
-) values of [M(arene)(L)] complexes in 
the function of their pKa[M(arene)(L)] constants (I = 0.20 M (KNO3)). b) 
Multilinear regression for calculating log K’(H2O/Cl
-) based on the shown 
equation. Used data are collected in Table S6.22,29,30,45,46,49,52-56 Outlier points 
are circled. 
 
constant; all used data are summarized in Table S6). The displayed 
constants (Figure 8.a) are in three different groups with their own 
fitting lines. However, applying multilinear regression and the 
log [(M(arene))2H-3] constants arranged the values in one group 
(Figure 8.b). The equation of this regression is: 
-0.24×log [(M(arene))2H-3] − 0.63×pKa[M(arene)(L)] + 4.56 = log K’(H2O/Cl
-) 
The first term of this equation takes the M(arene) part into 
consideration, while the second term describes the effect of 
bidentate ligand. This model is universal, as it can predict the 
chloride ion affinity of different half-sandwich M(arene) complexes, 
if the log β[(M(arene))2H‒3] and pKa[M(arene)(L)] constants are 
known. The main drawback is that only chloride ion free 
pKa[M(arene)(L)] values are acceptable in this model.  
After determining those constants, which govern the speciation in 
solution, we can compare them and find connections with 
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pKa[M(arene)(L)] values, the chloride ion affinity, the cytotoxicity 
against MES-SA cell line and resistance ratios in the same cell lines 



















Fig. 9 Comparison of the determined constants: basicity corrected stability 
constants (log K*), proton dissociation constants of coordinated water 
molecules (pKa), water-chloride exchange constants (log K’), the cytotoxicity 
in MES-SA cell lines (pIC50) and resistance ratio in MES-SA cell lines. N.d.=not 
determined. 
 
It is clearly seen that methylation of ligand improves anticancer 
activity. Although neocuproine complexes have the highest 
cytotoxicity, they have lower stability as compared to the other 
complexes, suggesting that they might be ligand carriers. High-
stability complexes of Ru(
6
-tol) are likely to lose their arene 
ligands. This process can explain the loss of cytotoxicity and may 
occur for Ru(
6
-p-cym) complexes as well. The MDR-selective 
complexes show the highest complex stability from all, combined 
with high pKa and high chloride ion binding capability. However, the 





 complex is not evident 
because of the slight differences in the respective constants. 
Together these data suggest that further factors should be 
considered, such as lipophilicity, redox potential or a specific 


















 organometallic cations 
formed with polypiridyl ligands were compared regarding their 
differences in structural, cytotoxic and aqueous solution behaviour. 
The structurally related bpy, dmb, phen and neo and their 
complexes were examined to investigate the effect of methylation 
and complexation of the ligands. Synthesis of complexes was 
performed in moderate-to-excellent yields. Based on the X-ray 
crystallographically determined structures, the change from p-
cymene to toluene has only a negligible effect on the complex 
structure, while in the investigated Rh complexes, longer bonds 
between the bidentate ligands and the metal centre could be 
found. The methyl groups distorted the structure, when they are 
present next to the coordinating atoms, namely there is an angle 
between the plane of the arene and the plane of bidentate ligand. 
The polypyridines and their complexes show anticancer activity in 
A2780 and MES-SA cancer cell lines; however, in A2780cis cell lines 
they have reduced effect. Phen and dmb and their half-sandwich Rh 
complexes showed paradoxical toxicity against multidrug resistant 
MES-SA/Dx5 cells. Interestingly, in all cases coordination to Ru 
caused a loss of activity and selectivity of these ligands.  
Generally, metal complexes with the structure 
[M(arene)(N,N)(H2O)]
2+
 show high stability, although stability 
constants could be determined only for Rh complexes by ligand 
competition studies. In case of neocuproine, the methyl groups next 
to the nitrogen atoms lower the stability of complexes due to steric 
congestion with the arene. This is clearly shown, when log K* 
(stability constant in which the different basicity of the ligand is 
taken into account) of complexes are compared with each other: 
9.78 (phen) > 9.01 (dmb) > 8.89 (bpy) > 3.93 (neo). The pKa value of 
coordinated water molecule is between 7.39-7.62 for Ru and 8.40-
8.88 for Rh compounds; thus, methylation has a small effect on this 
constant. Methyl groups have a great effect on the K’(H2O/Cl
-
) 
constants of Ru compounds containing neocuproine, decreasing 
them with one order of magnitude compared to 1,10-phenantroline 
(log K’(H2O/Cl
-
) = 1.79 vs. 0.93 for p-cymene and 1.68 vs. 0.87 for 
toluene complexes), which is also in connection with steric 
hindrance. 
A correlation was made between the hydrolytic properties and the 
water-chloride exchange constants, which is universal for Rh and Ru 
complexes as well. No direct correlation was seen between the 
determined equilibrium constants (stability, proton dissociation and 
chloride/water exchange constants) of these half-sandwich 
complexes and cytotoxicity. The studied complexes are highly 
stable, thus the liberation of the bidentate ligands is not likely 
(except for the neocuproine complexes). The loss of the cytotoxicity 
of the Ru complexes is suggested to be connected to the slow and 
irreversible decomposition processes, in which the half-sandwich 
structure of these Ru(II) complexes is destroyed due to the arene 




All solvents were of analytical grade and used without further 






-p-cym)(-Cl)Cl]2, RuCl3 × 3 H2O, 1-fmethyl-1,4-
cyclohexadiene, doxorubicin, cisplatin, KCl, AgNO3, Ag(CF3SO3), 
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Dulbecco’s Modified Eagle Medium (DMEM), RPMI 1640 with FBS, 
NaH2PO4, Na2HPO4 and KH2PO4 were purchased from Sigma-Aldrich 
in puriss quality. The P-gp inhibitor tariquidar is from Dr. S. Bates 
(NCI NIH). Ultrapure Milli-Q water was used for sample preparation. 
[M(arene)(N,N)Cl]Cl complexes were synthesized as previously 
described.
11,31-33
 Synthesis, yields and characterization is described 
in the Electronic Supplementary Information as well as 





-tol)(-Cl)Cl]2 was prepared 
according to literature procedures,
63




The exact concentration of the ligand stock solutions together with 
the proton dissociation constants were determined by pH-





 and the water ionization 
constant (Kw = 13.76).
66
 Detailed description of pH-potentiometry 








solutions were obtained by dissolving an exact amount of the 
dimeric precursor in water followed by addition of equivalent 
amounts of AgNO3 and filtration of AgCl precipitate. The exact 
concentrations of chloride-free metal ion stock solutions were 














 (i = 2 or 3) complexes.
45,46
 Stock 
solutions of dmb and neo were prepared with HNO3 to increase 
solubility, exact concentrations were calculated from the weight-in-
volume basis.  
The buffered samples were prepared in 20 mM phosphate buffer or 
in a modified phosphate buffered saline (PBS’) at pH 7.40. PBS’ 
contains 12 mM Na2HPO4, 3 mM KH2PO4, 1.5 mM KCl and 100.5 







corresponds to that of the human blood serum. Phosphate is the 
best choice for the pH range 6.0-7.4 because mostly it does not 
coordinate to these metal ions (except RAED complexes vide supra). 
 
UV-Vis spectrophotometric and 
1
H NMR specroscopy 
An Agilent Cary 8454 diode array spectrophotometer was used to 
record the UV-Vis spectra in the interval 200–800 nm. The path 
length was 0.5 or 1 cm. Only one of the proton dissociation 
constants of neo and dmb could be determined by 
spectrophotometric titrations. Complex formation kinetics was 
investigated with the use of tandem cuvette. Deprotonation of 
coordinated water molecule in complexes was followed by 
spectrophotometry. UV-Vis spectra were used to investigate the 
H2O/Cl
−
 exchange processes of complexes at 200 M concentration 
(500 M for en complexes), around pH 6.0 (20 mM phosphate 
buffer) as a function of chloride concentrations (0–310 mM).  
NMR spectroscopic studies were carried out on a Bruker Avance III 
HD Ascend 500 Plus instrument. For aqueous samples 
1
H NMR 
spectra were recorded with the WATERGATE water suppression 
pulse scheme using DSS internal standard. Deprotonation of 
coordinated water molecule in complexes was also followed by 
1
H NMR. Samples were made in a 10% (v/v) D2O/H2O mixture and 
were titrated at 25.0 °C, at I = 0.20 M (KNO3) at 1:1 metal-to-ligand 
ratio. The slower kinetic measurements were checked by NMR to 
see the endpoint of complex formation. Stability constants for the 
complexes of ethylenediamine and neocuproine were calculated by 
the computer program PSEQUAD
67
 based on 
1
H NMR spectra.  
In vitro cell studies 
Cell lines and culture conditions 
The human ovarian cancer cell line A2780 and its cisplatin resistant 
(A2780cis) counterpart, human uterine sarcoma cell lines MES-SA 
and the doxorubicin selected MES-SA/Dx5 were obtained from 
ATCC (American Type Culture Collection) (MES-SA: No. CRL-1976™, 
MES-SA-MES-SA/Dx5: No. CRL-1977™). The phenotype of the 
resistant cells was verified using cytotoxicity assays (Tables 1, 2 and 
S5, doxorubicin and cisplatin). Cells were cultivated in Dulbecco’s 
Modified Eagle Medium (DMEM, Sigma-Aldrich) and supplemented 
with 10% fetal bovine serum, 5 mM glutamine, and 50 units per mL 
penicillin and streptomycin (Life Technologies). All cell lines were 
cultivated at 37 °C under a humidified atmosphere containing 95% 
air and 5% CO2. 
 
Cell viability assay 
Cytotoxic effects were determined by the colorimetric microculture 
MTT assay.
68
 Cells were harvested from culture flasks by 
trypsinization, seeded in 100 μL aliquots into 96-well microculture 
plates (Sarstedt, Newton, USA) at 5000 cells per well and allowed to 
settle and resume exponential growth in drug-free complete culture 
medium for 12 h to 24 h. Ligands and complexes were diluted in 
complete culture medium and added to the plates. The complexes 
of the ligands were prepared in situ by mixing the ligand with an 
equimolar concentration of the organometallic cations using their 














. Following the addition of the serial dilutions of 
ligands and complexes and an incubation period of 72 h, the 
supernatant was removed and fresh medium supplemented with 
the MTT reagent (0.83 mg/mL) was added. Incubation with MTT at 
37 °C was terminated after 1 h by removing the supernatants and 
lysing the cells with 100 μL DMSO per well. Viability of the cells was 
measured spectrophotometrically by absorbance at 540 nm using 
an EnSpire microplate reader. Data were background corrected by 
subtraction of the signal obtained from unstained cell lysates and 
normalized to untreated cells. Curves were fitted with the Prism 
software
69
 using the sigmoidal dose–response model (comparing 
variable and fixed slopes). Curve fit statistics were used to 
determine the concentration of the test compound that resulted in 
50% toxicity (IC50). Evaluation is based on means from three 
independent experiments, each comprising three replicates per 
each concentration. Co-incubation experiments were also 
performed in the presence of the P-gp inhibitor tariquidar. 
Doxorubicin and cisplatin were used as positive controls. 
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